Evidence map›Paper›PMID 25299698›Full record

ArticlePloS one2014

Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer.

Yusra Al Dhaheri, Samir Attoub, Gaber Ramadan, Kholoud Arafat, Khuloud Bajbouj, Noushad Karuvantevida, Synan AbuQamar, Ali Eid, Rabah Iratni

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 114 citations in OpenAlex.

  1. Therapeutic Potential ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Cardioprotective effect ofFrontiers in pharmacology · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Frontiers in oncology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yusra Al DhaheriDepartment of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Samir AttoubDepartment of Pharmacology & Therapeutics, Faculty of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Gaber RamadanDepartment of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Kholoud ArafatDepartment of Pharmacology & Therapeutics, Faculty of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Khuloud BajboujDepartment of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Noushad KaruvantevidaDepartment of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Synan AbuQamarDepartment of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Ali EidDepartment of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha, Qatar.
Rabah IratniDepartment of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
United Arab Emirates University · AEQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn this study we investigated the in vitro and in vivo anticancer effect of carnosol, a naturally occurring polyphenol, in triple negative breast cancer.

resultsWe found that carnosol significantly inhibited the viability and colony growth induced G2 arrest in the triple negative MDA-MB-231. Blockade of the cell cycle was associated with increased p21/WAF1 expression and downregulation of p27. Interestingly, carnosol was found to induce beclin1-independent autophagy and apoptosis in MDA-MB-231 cells. The coexistence of both events, autophagy and apoptosis, was confirmed by electron micrography. Induction of autophagy was found to be an early event, detected within 3 h post-treatment, which subsequently led to apoptosis. Carnosol treatment also caused a dose-dependent increase in the levels of phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2). Moreover, we show that carnosol induced DNA damage, reduced the mitochondrial potential and triggered the activation of the intrinsic and extrinsic apoptotic pathway. Furthermore, we found that carnosol induced a dose-dependent generation of reactive oxygen species (ROS) and inhibition of ROS by tiron, a ROS scavenger, blocked the induction of autophagy and apoptosis and attenuated DNA damage. To our knowledge, this is the first report to identify the induction of autophagy by carnosol.

conclusionIn conclusion our findings provide strong evidence that carnosol may be an alternative therapeutic candidate against the aggressive form of breast cancer and hence deserves more exploration.

Indexed as

1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltAbietanesAntineoplastic Agents, PhytogenicApoptosisApoptosis Regulatory ProteinsAutophagyBeclin-1Cell Line, TumorCell ProliferationCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27DNA DamageFemaleFree Radical ScavengersG2 Phase Cell Cycle CheckpointsHumans1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltAbietanesAntineoplastic Agents, PhytogenicApoptosis Regulatory ProteinsBeclin-1BECN1 protein, humancarnosolCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Free Radical ScavengersMAPK1 protein, humanMembrane ProteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Reactive Oxygen Species

Identifiers

PMID25299698
PMCPMC4192122
OpenAlexW2048329244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.